论文部分内容阅读
目的观察阿奇霉素治疗成人支原体肺炎的临床疗效。方法420例患者随机分为阿奇霉素组220例;红霉素组200例,两组的一般治疗及对症治疗方法相同,在一般治疗的基础上分别加用阿奇霉素和红霉素,观察两组患者在临床疗效及副作用方面的差异。结果阿奇霉素组比红霉素组临床疗效好。统计学比较结果差异有显著性(P<0.05)。阿奇霉素与红霉素比较胃肠道反应、局部疼痛、肝功能异常率明显降低,比较结果差异有显著性(P<0.05)。结论阿奇霉素治疗成人支原体肺炎临床疗效好、副作用少。
Objective To observe the clinical efficacy of azithromycin in the treatment of adult mycoplasma pneumonia. Methods A total of 420 patients were randomly divided into azithromycin group (n = 220) and erythromycin group (n = 200). The general treatment and symptomatic treatment were the same in both groups. Azithromycin and erythromycin were added respectively on the basis of general treatment. Clinical efficacy and side effects differences. The results of azithromycin group than erythromycin clinical efficacy. Statistical differences were statistically significant (P <0.05). Azithromycin and erythromycin compared gastrointestinal reactions, local pain, abnormal liver function was significantly lower, the difference between the results was significant (P <0.05). Conclusion Azithromycin has a good clinical curative effect in treating mycoplasma pneumonia in adults with few side effects.